RAYNAUD'S PHENOMENON
Open Access
- 1 November 1996
- journal article
- review article
- Published by Elsevier BV in Rheumatic Disease Clinics of North America
- Vol. 22 (4), 765-781
- https://doi.org/10.1016/s0889-857x(05)70300-8
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohortJournal of Vascular Surgery, 1996
- Possible Role of Endothelin in Endothelial Regulation of Vascular ToneAnnual Review of Pharmacology and Toxicology, 1995
- Angiotensin Converting Enzyme Inhibitors in Raynaud??s PhenomenonDrugs, 1994
- EndothelinsDrugs, 1993
- The Influence of Different Beta‐Blocking Drugs on the Peripheral Circulation in Raynaud's Phenomenon and in HypertensionThe Journal of Clinical Pharmacology, 1992
- Endothelin, an endothelial‐dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic actionArthritis & Rheumatism, 1991
- Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenonAmerican Heart Journal, 1991
- Acute Effects and Mechanism of Action of Ketanserin in Patients with Primary Raynaudʼs PhenomenonJournal of Cardiovascular Pharmacology, 1990
- Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ, 1989
- LOWER LIMB AMPUTATION SECONDARY TO LARGE VESSEL INVOLVEMENT IN SCLERODERMARheumatology, 1988